RecruitingPhase 1NCT05714072
Blood
Primary myelofibrosis
97
studies recruiting now
as of 7 Sept 2026
648
studies registered in total
as of 7 Sept 2026
11
countries with a recruiting site
as of 7 Sept 2026
3 Sept 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07802405
Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis
RecruitingPhase 1NCT07469891
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
RecruitingPhase 2NCT06661915
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 3NCT07357727
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 97 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Primary myelofibrosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Primary myelofibrosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (JAK2, MPL, TET2, CALR).
Treatments being studied
4 approved treatments and 17 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Ruxolitinib Phosphate (Jakafi)Approved: Momelotinib Dihydrochloride (Ojjaara)Approved: Pacritinib Citrate (Vonjo)Approved: Fedratinib Hydrochloride (Inrebic)
Phase 3Pacritinib
Phase 3Navitoclax
Phase 3Fedratinib
Phase 3Pomalidomide (Imnovid)
Phase 3Ruxolitinib (Jakavi)
Phase 3Momelotinib
Phase 2Lcl-161
Phase 2Ns-018
+ 9 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).